One Vision, One Culture, One Team
Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA
Rich Whitworth | | Interview
This article was published in our sister publication, The Small Molecule Manufacturer, which celebrates the field of small molecule drug development and manufacturing with interviews and articles focusing on success stories, equipment, and new processing techniques. Read more about The Small Molecule Manufacturer here https://themedicinemaker.com/manufacture/small-but-never-forgotten
As a leader of a company that must innovate to succeed, how do you maintain momentum?
Innovation is in our DNA at Agilent – and that philosophy must extend beyond the R&D community. Yes, we must develop products at the cutting edge for our customers, but we must also be innovative when it comes to how we work with our customers – and how we run internal operations. It’s easy to talk about these things – but do you actually run the business this way?
When I first took on this role in 2015, I discussed profitability goals with the investment community, as you might expect. “Well, Mike,” they said. “Why not just cut your R&D budget in half, and you’ll reach your goals much faster…”
“That would destroy who we are,” I replied. “We are an innovation driven company.” And that’s why we are willing to invest such a high percentage of our revenue into R&D – over $1 billion in the next three years. We’re also the only company in our space with a long-term basic research effort – Agilent Labs, staffed with world-class scientists developing the technologies of the future.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.